Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unisynth Group is a prominent Indian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Operating primarily as a Contract Development and Manufacturing Organization (CDMO), the company serves a global clientele across the pharmaceutical and specialty chemical industries. Their core expertise lies in complex chemical synthesis and process chemistry, with a product portfolio covering therapeutic areas such as cardiovascular health, diabetes, and gastroenterology. Unisynth maintains state-of-the-art manufacturing facilities that adhere to international quality standards, including Good Manufacturing Practices (GMP). The group is committed to providing cost-effective and scalable manufacturing solutions for both generic and innovator pharmaceutical companies. Through its subsidiaries, Unisynth Chemicals and Unisynth Pharmaceuticals, the group has established a significant presence in international markets including Europe and Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unisynth Group.